Travera uses a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells.
Travera's investors include National Science Foundation, MedTech Innovator.
Travera is headquartered in Cambridge, United States.
Travera uses a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells.
Travera is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Travera — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/travera. Accessed August 14, 2026.
VCBacked. (2023). Travera — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/travera
{{cite web |title=Travera — Funding & Investors |url=https://www.vcbacked.co/company/travera |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated